Interference in the measurement of CA-125 in peritoneal fluid**Presented at the Forty-Third Annual Meeting of The American Fertility Society, September 28 to 30, 1987, Reno, Nevada.-Reference-Cited by-同舟云学术

Interference in the measurement of CA-125 in peritoneal fluid**Presented at the Forty-Third Annual Meeting of The American Fertility Society, September 28 to 30, 1987, Reno, Nevada.

Published:1988-03 Issue:3 Volume:49 Page:547-550
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Williams R. Stan,Venkateswara Rao Ch.,Yussman Marvin A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference5 articles.

1. Tissue distribution of a coelomic epithelium related antigen recognized by the monoclonal antibody to OC125;Kabawat;Lab Invest,1983

2. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer;Bast;N Engl J Med,1983

3. Elevated serum concentrations of CA-125 in patients with advanced endometriosis;Barbieri;Fertil Steril,1986

4. Revised classification of endometrium: 1985;American Fertility Society;Fertil Steril,1985

5. The use of CA-125 in the diagnosis and management of endometriosis;Pittaway;Fertil Steril,1986

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of endometriosis, cycle stage, lymphocyte suppression and pregnancy on CA-125 levels in peritoneal fluid and serum in baboons;Human Reproduction;2005-07-21

2. High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis;Archives of Gynecology and Obstetrics;2004-07-09

3. Serum and peritoneal CA-125 levels as diagnostic test for endometriosis;European Journal of Obstetrics & Gynecology and Reproductive Biology;1996-05

4. No evidence of the hook effect in peritoneal fluid CA 125 measurement using immunoenzymatic second generation assays: comparison with immunoradiometric assays;European Journal of Obstetrics & Gynecology and Reproductive Biology;1995-09

5. Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies;Journal of Assisted Reproduction and Genetics;1995-04